3 results  1 of 1 

1 Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching
Ayman Tantawy, Chul-Min Ahn, Dong-Ho Shin, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Meong-Ki Hong
Yonsei Med J.2017;58(2):290-295.   Published online 2017 January 16     DOI: http://dx.doi.org/10.3349/ymj.2017.58.2.290
      
2 Acute and Long-Term Angiographic Outcomes of Side Branch Stenosis after Randomized Treatment of Zotarolimus-, Sirolimus-, and Paclitaxel-Eluting Stent for Coronary Artery Stenosis
Bong-Ki Lee, Young-Hak Kim, Duk-Woo Park, Sung-Cheol Yun, Jung-Min Ahn, Hae Geun Song, Jong-Young Lee, Won-Jang Kim, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Jae-Hwan Lee, In-Whan Seong, Seong-Wook Park, Seung-Jung Park
J Korean Med Sci.2012;27(12):1499-1506.   Published online 2012 December 7     DOI: http://dx.doi.org/10.3346/jkms.2012.27.12.1499
      
3 Simultaneous Multi-Vessel Subacute Stent Thromboses in Zotarolimus-Eluting Stents
Yong-Hyun Kim, Soon Yong Suh, Seong Hwan Kim, Sang-Yup Lim, Seung-Young Roh, Ji-Bak Kim, Woo Hyuk Song, Jeong Cheon Ahn
Korean Circ J.2010;40(5):243-246.   Published online 2010 May 27     DOI: http://dx.doi.org/10.4070/kcj.2010.40.5.243
      

 1 of 1